143 related articles for article (PubMed ID: 29678478)
21. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.
Marconi A; Borroni RG; Truzzi F; Longo C; Pistoni F; Pellacani G; Pincelli C
Exp Dermatol; 2015 May; 24(5):396-8. PubMed ID: 25739328
[TBL] [Abstract][Full Text] [Related]
23. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.
Valyi-Nagy K; Kormos B; Ali M; Shukla D; Valyi-Nagy T
Mol Vis; 2012; 18():588-92. PubMed ID: 22419851
[TBL] [Abstract][Full Text] [Related]
24. CD271 determines migratory properties of melanoma cells.
Radke J; Roßner F; Redmer T
Sci Rep; 2017 Aug; 7(1):9834. PubMed ID: 28852061
[TBL] [Abstract][Full Text] [Related]
25. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
[TBL] [Abstract][Full Text] [Related]
26. low neurotrophin receptor CD271 regulates phenotype switching in melanoma.
Restivo G; Diener J; Cheng PF; Kiowski G; Bonalli M; Biedermann T; Reichmann E; Levesque MP; Dummer R; Sommer L
Nat Commun; 2017 Dec; 8(1):1988. PubMed ID: 29215016
[TBL] [Abstract][Full Text] [Related]
27. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells.
Morita S; Mochizuki M; Wada K; Shibuya R; Nakamura M; Yamaguchi K; Yamazaki T; Imai T; Asada Y; Matsuura K; Sugamura K; Katori Y; Satoh K; Tamai K
Cancer Lett; 2019 Oct; 461():144-152. PubMed ID: 31325530
[TBL] [Abstract][Full Text] [Related]
28. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
29. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
[TBL] [Abstract][Full Text] [Related]
30. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
Chandrasekaran S; DeLouise LA
Biomaterials; 2011 Dec; 32(35):9316-27. PubMed ID: 21917310
[TBL] [Abstract][Full Text] [Related]
31. Defective autophagy leads to the suppression of stem-like features of CD271
Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of serum NGF level and CD271 expression in patients with acute B lymphoid leukemia].
Han XH; Xu KL; Zeng LY; Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1273-6. PubMed ID: 22040987
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
[TBL] [Abstract][Full Text] [Related]
34. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
35. Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells
Speigl L; Janssen N; Weide B; Sinnberg T; Pawelec G; Shipp C
Front Biosci (Landmark Ed); 2023 Sep; 28(9):193. PubMed ID: 37796710
[TBL] [Abstract][Full Text] [Related]
36. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal.
Miller DD; Emley A; Yang S; Richards JE; Lee JE; Deng A; Hoang MP; Mahalingam M
Mod Pathol; 2012 Apr; 25(4):505-15. PubMed ID: 22157936
[TBL] [Abstract][Full Text] [Related]
37. Age-related decrease in CD271(+) cells in human skin.
Akamatsu H; Hasegawa S; Yamada T; Mizutani H; Nakata S; Yagami A; Matsunaga K
J Dermatol; 2016 Mar; 43(3):311-3. PubMed ID: 26300383
[TBL] [Abstract][Full Text] [Related]
38. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
Palazzo E; Marconi A; Pincelli C; Morasso MI
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
[TBL] [Abstract][Full Text] [Related]
39. CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens.
Furuta J; Inozume T; Harada K; Shimada S
J Invest Dermatol; 2014 May; 134(5):1369-1377. PubMed ID: 24226422
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic superiority for cartilage repair by CD271-positive marrow stromal cell transplantation.
Mifune Y; Matsumoto T; Murasawa S; Kawamoto A; Kuroda R; Shoji T; Kuroda T; Fukui T; Kawakami Y; Kurosaka M; Asahara T
Cell Transplant; 2013; 22(7):1201-11. PubMed ID: 23044363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
